Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
10/2003
10/02/2003US20030186448 Such as heat resistant diazomethyl compounds; kits for solid phase nucleic acid synthesis
10/02/2003US20030183812 Fluorinated crosslinked electro-optic materials and electro-optic devices therefrom
10/01/2003EP1347985A2 Biotin derivatives, methods for making same and uses thereof as vectors
10/01/2003EP1347762A2 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
10/01/2003EP0811008B1 Bicyclic benzazepine derivatives as vasopressin antagonists
10/01/2003CN1446217A Beta-carboline derivatives useful as inhibitors of phosphodiesterase
10/01/2003CN1445229A Method for preparing (3S,6aR)-1,3-dibenzyl-tetrahydro-1H-thieno [3,4-d] imidazole-2(3H)-ketone-4-normal pentanoic acid
10/01/2003CN1122696C Poly (paraphenylene vinylene) derivatives and their use as electroluminescen materials
10/01/2003CN1122669C Novel 8H thiophene [2,3-b] pyrrolinezine-8-on compound, its preparing method and their medicinal compounds containing them
09/2003
09/30/2003US6627755 Quinazolin-4-one AMPA antagonists
09/30/2003US6627636 Benzo(3,4)pyrido(3,2-a)cycloctenes and benzo(3,4)pyrido-(3,2-a)oxocins, -thiocins or azocines; anticholesterol, antilipemic agents; lowering LDL cholesterol; increasing HDl cholesterol; hypertriglyceridemia and atherosclerosis
09/30/2003US6626566 Compounds for electronic devices
09/25/2003WO2003078647A2 Aza-benzothiopyranoindazoles with antitumor activity
09/25/2003WO2003078646A2 Aza-thioxanthenones with antitumor activity
09/25/2003WO2003022847A3 Process for the direct preparation of pyrrolo[3,4-c]pyrroles
09/25/2003US20030181502 Methods of treating sepsis
09/25/2003US20030181457 Tertiary amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular and sexual disorders
09/24/2003EP1346730A1 Pretargeting methods and novel pretargeting conjugates
09/24/2003EP1345943A2 Inhibitors of papilloma virus
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345907A2 7-heterocyclyl quinoline and thieno 2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
09/24/2003EP1345609A1 Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mglur 1 antagonists
09/24/2003EP1051415B1 Benzamide derivatives as vasopressin antagonists
09/24/2003CN1444587A Dihydropyridine soft drug and related to composition and method
09/24/2003CN1444481A Protease inhibitors
09/24/2003CN1122039C Process for reducing prochiral ketone to produce optically active alcohol of high optical purity
09/24/2003CN1122037C Thiophene [2,3,-d] hybar X compound and its preparing method, use and medical composition containing it
09/24/2003CN1122036C Intermediates and process for preparing danzapine
09/23/2003CA2227696C Process for synthesizing carbapenem side chain intermediates
09/18/2003WO2003022848A3 Process for the preparation of diketopyrrolopyrroles
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176628 Polythiophenes formed form monomers such as (2,3-dihydro-thieno(3,4-b)(1,4)dioxin-2-yl-methoxy)-acetic acid, for use as coatings, printable pastes or electroconductive layers
09/18/2003US20030176454 N-coating heterocyclic compounds
09/18/2003US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
09/18/2003US20030176361 Having cytoprotective activity and protective activity for neuroinflammation, and neurodegenerative disorders; for use in therapy of stroke, cerebral ischemia, myocardial infarction, myocardial ischemia, chronic heart failure, inflammation
09/17/2003EP1343561A1 Serine protease inhibitors
09/17/2003EP1200445B1 Thienopyranecarboxamide derivatives
09/17/2003EP1192163B1 DITHIEPINO 6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
09/17/2003EP0946179B1 Use of olanzapine or a pharmaceutically acceptable salt for the manufacture of a medicament for the treatment of autism and mental retardation
09/17/2003CN1121398C Alicyclic acylated heterocyclic derivatives
09/16/2003US6620810 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxamides as antiviral agents
09/16/2003CA2249009C Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors
09/16/2003CA2047857C (quinolin-2-ylmethoxy)heterotetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
09/12/2003WO2003074532A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
09/12/2003WO2003074531A1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
09/12/2003WO2003074530A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003WO2003074529A2 iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS
09/12/2003WO2003045942A3 Chemokine receptor antagonists and methods of use thereof
09/12/2003CA2478050A1 Indolyl-urea derivatives of thienopyridines useful as anti-angiogenic agents
09/12/2003CA2477721A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
09/12/2003CA2477667A1 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
09/12/2003CA2477125A1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
09/11/2003US20030171426 Antilipemic agents; atherosclerosis; anticholesterol agents; cardiovascular disorders
09/11/2003US20030171423 Enzyme inhibitor for treating HIV infections in mammals; viricides; patient is suffering from a multi-drug resistant HIV infection; AIDS therapy
09/11/2003US20030171394 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171219 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
09/10/2003EP1037633B1 Antiviral compounds
09/10/2003EP0983236B1 Process for the preparation of an oxirane, aziridine or cyclopropane
09/10/2003EP0808317B1 Thienopyrimidine derivatives, their production and use
09/10/2003CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives
09/09/2003US6617330 For controlling and preventing pests
09/09/2003US6617321 2-methyl-thieno-benzodiazepine formulation
09/04/2003WO2003072570A1 Antidiabetic agents
09/04/2003WO2003045313A3 2-aminoquinoline compounds
09/04/2003WO2003018002A3 Cyclopropyl and cyclobutyl epothilone analogs
09/04/2003US20030166935 Spiroazabicyclic heterocyclic compounds
09/04/2003US20030166926 Pyrroloazepine derivatives
09/04/2003US20030166641 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders
09/04/2003US20030165962 Comprises biotin/avidin immobilized macromolecules for converting, separating or concentrating microorganism, proteins and/or nucleic acids
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1340500A1 Antidiabetic agents
09/03/2003EP1339699A1 Substituted amidoalkyl uracils and the use thereof
09/03/2003EP1339657A1 Method for hydrogenating c-c double bonds
09/03/2003EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
09/03/2003EP0285671B1 Pyridine derivatives
09/03/2003CN1440413A Method for preparing (+)-biotine
09/03/2003CN1440412A Thienopyrrolidinones
09/03/2003CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
09/03/2003CN1440401A Amino substituted dibenzothiophene derivatives for treatmnt of disorders mediated by NP Y5 receptor
09/03/2003CN1440400A Bicyelyl or heterobicyclylmethanesulfonylamino-substituted N-hydroxyformamides
09/02/2003US6613905 Chemokine receptor antagonists and methods of use therefor
09/02/2003US6613903 Such as 7-(benzoylamino-methyl)-2-(oxalyl-amino)-4,5,6,7-tetrahydro-thieno(2,3 -c)pyridine-3-carboxylic acid for treatment of diabetes, insulin resistance, and obesity
09/02/2003US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease
08/2003
08/28/2003WO2003070710A1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
08/28/2003WO2003070706A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003WO2003070245A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
08/28/2003WO2003070241A1 Inhibitors of tubulin polymerization
08/28/2003WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003US20030162972 Pyridyl alkane acid amides as cytostatics and immunosupressives
08/28/2003US20030162958 Process for preparing a compound containing a heteroaromatic group with one or more ether substituents
08/28/2003US20030162795 Administering a bicyclic pyrimidine and pyridine derivative to a mammal suffering from hyperproliferative disorders
08/28/2003US20030162784 Pyridazinone aldose reductase inhibitors
08/28/2003US20030162774 Derivatives of sulfonylurea, sulfonylthiourea, sulfonylguanidine, thioacylsufonamide and acylsulfonamide; useful for treating thromobis
08/28/2003US20030162198 Medical diagnosis; complexing to Dna; calibration
1 ... 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 ... 214